← Open Payments lookup

MATTHEW GELLER: Open Payments

NPI 1346317013 · LONG BRANCH, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$826 in 54 payments from 10 companies in 2025. Trend: 2023 $275 · 2024 $90 · 2025 $826

Food & beverage: $826
CompanyPaymentsAmount
ABBVIE INC.23$289
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$114
Alkermes, Inc.6$109
Axsome Therapeutics, Inc.5$88
Vanda Pharmaceuticals Inc.5$78
Teva Pharmaceuticals USA, Inc.3$56
E.R. Squibb & Sons, L.L.C.2$34
Neurocrine BioSciences, Inc.1$21
Otsuka America Pharmaceutical, Inc.1$20
Braeburn Inc.1$17

Products named: VRAYLAR, CAPLYTA, Auvelity, FANAPT, ARISTADA, UZEDY, LYBALVI, COBENFY.

Industry payments across NJ — which companies pay providers there.